SynthesisBMC geriatrics2026
Risk of antidepressant-induced hyponatremia in geriatric patients: a systematic review and meta-analysis.
Synthesis in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHyponatremia is a frequent electrolyte disorder in clinical practice and is particularly prevalent among elderly populations. Antidepressants have been identified as an important pharmacological contributor. However, the event rate, overall risk, and differences across antidepressant classes remain incompletely characterized. This systematic review and meta-analysis aimed to quantify the event rate and comparative risk of antidepressant-induced hyponatremia in geriatric populations.
methodsPubMed, Web of Science, and EMBASE were systematically searched from inception to February 5, 2026. A random-effects model was applied to estimate pooled event rates and risk ratios (RRs) among antidepressant users. Subgroup analyses were conducted according to antidepressant classes and individual compounds. Head-to-head comparisons were performed to evaluate differences in hyponatremia risk across antidepressant classes.
resultsA total of 21 cohort studies, comprising 2,115,187 geriatric antidepressant users, were included. The pooled event rates of any hyponatremia and clinically relevant hyponatremia were 0.0825 (95% confidence interval [CI]: 0.0566-0.1125) and 0.0287 (95% CI: 0.0117-0.0526), respectively. Serotonin and noradrenaline reuptake inhibitors (SNRIs) demonstrated the highest event rates (0.1040 and 0.0503, respectively), followed by selective serotonin reuptake inhibitors (SSRIs: 0.0981 and 0.0275, respectively). Antidepressant use was associated with a significantly increased risk of any hyponatremia (RR = 2.43, 95% CI: 1.42-4.14, P = 0.001) and clinically relevant hyponatremia (RR = 2.96, 95% CI: 1.57-5.57, P < 0.001), resulting in an absolute increase of 0.0037 (95% CI: 0.0011-0.0080) and 0.0046 (95% CI: 0.0013-0.0108) in event rate compared with non-users, respectively. This increased risk remained significant in subgroups of SSRIs (RR = 2.40 and 3.22, respectively) and SNRIs (RR = 2.90 and 2.91, respectively). Head-to-head comparisons indicated that SNRIs were associated with higher risks of both any and clinically relevant hyponatremia compared with SSRIs. In contrast, mirtazapine was associated with significantly lower risks of any hyponatremia (RR = 0.61, 95% CI: 0.39-0.61, P = 0.031) and clinically relevant hyponatremia (RR = 0.49, 95% CI: 0.39-0.61, P < 0.001) compared with SSRIs.
conclusionAntidepressant use in geriatric patients is associated with an increased risk of hyponatremia, with clinically relevant differences observed among antidepressant classes. SNRIs appear to confer a relatively higher risk, whereas mirtazapine may represent a comparatively safer option. However, these findings should be interpreted considering substantial heterogeneity and potential residual confounding among observational studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.